The sharp decline of beta estrogen receptors expression in long-lasting ulcerative-associated carcinoma

Scandinavian Journal of Gastroenterology

Volumn 50, Issue 8, 2015, Pages 1002-1010

  Principi, Mariabeatrice ^a   Scavo, Maria Principia ^a   Piscitelli, Domenico ^a   Villanacci, Vincenzo ^b   Lovero, Rosa ^a   Losurdo, Giuseppe ^a   Girardi, Bruna ^a   Ierardi, Enzo ^a   Di Leo, Alfredo ^a  

^a UNIVERSITY OF BARI   (Italy)

^b SPEDALI CIVILI   (Italy)

Author keywords

Colorectal carcinoma; Dysplasia; Estrogen receptors; Pancolitis; Ulcerative colitis

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; KI 67 ANTIGEN; BIOLOGICAL MARKER;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GASTROINTESTINAL DYSPLASIA; HIGH GRADE DYSPLASIA; HUMAN; IMMUNOHISTOCHEMISTRY; LOW GRADE DYSPLASIA; MALE; PANCOLITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; STOMACH EPITHELIUM; TUNEL ASSAY; ULCERATIVE COLITIS; COLITIS, ULCERATIVE; COLON; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DISEASE COURSE; METABOLISM; MIDDLE AGED; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY;

ADULT; AGED; BIOMARKERS; COLITIS, ULCERATIVE; COLON; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84929845507     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2014.978817     Document Type: Article

References (45)

1. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990;336:357-9.
2. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992;103:1444-51.
3. Nuako KW, Ahlquist DA, Mahoney DW Schaid DJ, Siems DM, Lindor NM. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology 1998;115:1079-83.
4. Gupta RB, Harpaz N, Itzkowitz S, Hossain S, Matula S, Kornbluth A, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007;133:1099-105.
5. Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004;126:451-9.
6. Itzkowitz SH, Present DH. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005;11:314-21.
7. Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002;51:V10-12.
8. Collins PD, Mpofu C, Watson AJ, Rhodes JM. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2006:CD000279.
9. Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 2004;126:1634-48.
10. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-68.
11. Eaden J, Abrams K, McKay H, Denley H, Mayberry J. Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. J Pathol 2001;194:152-7.
12. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 2003;124:544-60.
13. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994;343:71-4.
14. Newcomb PA, Storer BE. Postmenopausal hormone use and riskof large-bowelcancer. JNatlCancer Inst1995;87:1067-71.
15. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, et al. Human estrogen receptor betagene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 1997;82:4258-65.
16. Cavallini A, Messa C, Pricci M, Caruso ML, Barone M, Di Leo A. Distribution of estrogen receptor subtypes, expression of their variant forms, and clinicopathological characteristics of human colorectal cancer. Dig Dis Sci 2002;47: 2720-8.
17. Francavilla A, Di Leo A, Polimeno L, Conte D, Barone M, Fanizza G, et al. Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue. Gastroenterology 1987;93:1301-6.
18. Di Leo A, Messa C, Russo F, Misciagna G, Guerra V, Taveri R, et al. Prognostic value of cytosolic estrogen receptors in human colorectal carcinoma and surrounding mucosa. Preliminary results. Dig Dis Sci 1994;39:2038-42.
19. Jassam N, Bell SM, Speirs V, Quirke P. Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol Rep 2005;14:17-21.
20. Fujii S, Tominaga K, Kitajima K, Takeda J, Kusaka T, Fujita M, et al. Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis. Gut 2005;54:1287-92.
21. Tominaga K, Fujii S, Mukawa K, Fujita M, Ichikawa K, Tomita S, et al. Prediction of colorectal neoplasia by quantitative methylation analysis of estrogen receptor gene in nonneoplastic epithelium from patients with ulcerative colitis. Clin Cancer Res 2005;11:8880-5.
22. Moore HM, Kelly AB, Jewell SD, McShane LM, Clark DP, Greenspan R, et al. Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol 2011;119:92-101.
23. Cuzick J, Dowsett M, Pineda S, Wale C, Salter J, Quinn E, et al. Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. J Clin Oncol 2011;29:4273-8.
24. Lukas M. Inflammatory bowel disease as a risk factor for colorectal cancer. Dig Dis 2010;28:619-24.
25. Sebastian S, Hernández V, Myrelid P, Kariv R, Tsianos E, Toruner M, et al. Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I). J Crohns Colitis 2014;8:5-18.
26. Lakatos PL, Lakatos L. Challenges in calculating the risk for colorectal cancer in patients with ulcerative colitis. Clin Gastroenterol Hepatol 2012;10:1179.
27. Reenaers C, Belaiche J, Louis E. Impact of medical therapies on inflammatory bowel disease complication rate. World J Gastroenterol 2012;18:3823-7.
28. Andersen NN, Jess T. Has the risk of colorectal cancer in inflammatory bowel disease decreased? World J Gastroenterol 2013;19:7561-8.
29. Van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, et al. Second European evidencebasedconsensusonthediagnosisandmanagementofulcerative colitis part 3: special situations. J Crohns Colitis 2013;7:1-33.
30. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC. Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 2004;64:423-8.
31. Planey SL, Kumar R, Arnott JA. Estrogen receptors (ERa versus ERb): friends or foes in human biology? J Recept Signal Transduct Res 2014;34:1-5.
32. Kerdivel G, Flouriot G, Pakdel F. Modulation of estrogen receptor alpha activity and expression during breast cancer progression. Vitam Horm 2013;93:135-60.
33. Di Leo A, Barone M, Maiorano E, Tanzi S, Piscitelli D, Marangi S, et al. ER-beta expression in large bowel adenomas: implications in colon carcinogenesis. Dig Liver Dis 2008;40:260-6.
34. Barone M, Tanzi S, Lofano K, Scavo MP, Pricci M, Demarinis L, et al. Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice. Carcinogenesis 2010;31:269-74.
35. Principi M, Di Leo A, Pricci M, Scavo MP, Guido R, Tanzi S, et al. Phytoestrogens/insoluble fibers and colonic estrogen receptor b: randomized, double-blind, placebocontrolled study. World J Gastroenterol 2013;19:4325-33.
36. Hardy RG, Meltzer SJ, Jankowski JA. ABC of colorectal cancer. Molecular basis for risk factors. BMJ 2000;321: 886-9.
37. Tanaka T. Development of an inflammation-associated colorectal cancer model and its application for research on carcinogenesis and chemoprevention. Int J Inflam 2012; 2012:658786.
38. Principi M, De Tullio N, Scavo MP, Piscitelli D, Marzullo A, Russo S, et al. Estrogen receptors expression in long-lasting ulcerative pancolitis with and without dysplasia: a preliminary report. Scand J Gastroenterol 2012;47:1253-4.
39. Principi M, Barone M, Pricci M, De Tullio N, Losurdo G, et al. Ulcerative colitis: From inflammation to cancer. Do estrogen receptors have a role? World J Gastroenterol 2014;20:11496-504.
40. Barone M, Scavo MP, Papagni S, Piscitelli D, Guido R, Di Lena M, et al. ERb expression in normal, adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis. Scand J Gastroenterol 2010;45:1320-8.
41. Campbell-Thompson M, Lynch IJ, Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res 2001;61:632-40.
42. Jiang H, Teng R, Wang Q, Zhang X, Wang H, Wang Z, et al. Transcriptional analysis of estrogen receptor alpha variant mRNAs in colorectal cancers and their matched normal colorectal tissues. J Steroid Biochem Mol Biol 2008;112: 20-4.
43. Armstrong CM, Billimek AR, Allred KF, Sturino JM, Weeks BR, Allred CD. A novel shift in estrogen receptor expression occurs as estradiol suppresses inflammationassociated colon tumor formation. Endocr Relat Cancer 2013;20:515-25.
44. Hsu HH, Cheng SF, Chen LM, Liu JY, Chu CH, Weng YJ, et al. Over-expressed estrogen receptor-alpha up-regulates hTNF-alpha gene expression and downregulates beta-catenin signaling activity to induce the apoptosis and inhibit proliferation of LoVo colon cancer cells. Mol Cell Biochem 2006;289:101-9.
45. Arasaradnam RP, Khoo K, Bradburn M, Mathers JC, Kelly SB. DNA methylation of ESR-1 and N-33 in colorectal mucosa of patients with ulcerative colitis (UC). Epigenetics 2010;5:422-6.